Prostate Cancer Trial, Recruiting NCT05672485 Sponsor: First Affiliated Hospital Xi'an Jiaotong University Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05672485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are highly suspected of having prostate cancer based on one or more of the following: a notable rise in their PSA blood test results over time (specific thresholds apply depending on their PSA level); a close family member (parent, sibling, or child) who has had prostate cancer; or a prostate MRI scan that returned a score of 3 or higher on a standard rating scale called PI-RADS
  • People who have already been diagnosed with prostate cancer through a biopsy or surgical tissue sample
  • People who have recent blood test results (from within the past month) and have had at least two imaging scans (such as CT, MRI, PET/CT, ultrasound, or similar)
  • People who are able to complete the study examinations independently
  • People who are willing to take part and have signed a consent form

Who may not be able to join:

  • People who have a history of another type of cancer (other than prostate cancer)
  • People with serious liver or kidney problems
  • People for whom it may not be possible to obtain tissue test results or who cannot be followed up over a longer period of time
  • People whose relevant past scan images or medical records are not available
  • People who would have difficulty cooperating with the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rui Gao, First Affiliated Hospital Xi'an Jiaotong University

Phone: 0086-13772488039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Registry
ClinicalTrials.gov
Start date
5 January 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

99mTc-P137 SPECT/CT imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov